STUDYID,USUBJID,SUBJID,SITEID,AGE,AGEU,SEX,RACE,RACEN,COUNTRY,COUNTRYC,REGION,REGIONN,SAFFL,ITTFL,HITTFL,TEVLFL,CAEVLFL,ARM,TRTP,TRTPN,TRTA,TRTAN,HENT1ST,HENT1STN,IESEQ,PARAM,PARAMCD,PARCAT1,AVAL,AVALC
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,1.0,Histological/cytological confirmation of metastatic tissue (not primary tumor) by a central pathology laboratory (H&E stain) to ensure sufficient material is available for later hENT1 analysis.,IN02,INCLUSION,0.0,N
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,1.0,Histological/cytological confirmation of metastatic tissue (not primary tumor) by a central pathology laboratory (H&E stain) to ensure sufficient material is available for later hENT1 analysis.,IN02A,INCLUSION,0.0,N
CO-101-001,CO-101-001-086-007,01086007,086,74.0,YEARS,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,1.0,Histological/cytological confirmation of metastatic tissue (not primary tumor) by a central pathology laboratory (H&E stain) to ensure sufficient material is available for later hENT1 analysis.,IN02A,INCLUSION,0.0,N
